{"id":"https://openalex.org/W4230190734","doi":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c","title":"Treatment sequencing in metastatic castration resistant prostate cancer (mCRPC) after progression under an androgen receptor signaling inhibitor (ARSI) and to docetaxel: results in long responders to previous ARSIs","display_name":"Treatment sequencing in metastatic castration resistant prostate cancer (mCRPC) after progression under an androgen receptor signaling inhibitor (ARSI) and to docetaxel: results in long responders to previous ARSIs","publication_year":2020,"publication_date":"2020-09-02","ids":{"openalex":"https://openalex.org/W4230190734","doi":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c"},"language":"en","primary_location":{"id":"doi:10.26226/morressier.5f4d10acb0f0f3411b83095c","doi":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c","is_oa":false,"landing_page_url":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011987412","display_name":"Gil Falc\u00e3o","orcid":"https://orcid.org/0000-0003-1048-6967","observed_orcids":["https://orcid.org/0000-0003-1048-6967"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"gil falcao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5011987412"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.9229999780654907},{"id":"https://openalex.org/keywords/androgen-receptor-pathway-inhibitors","display_name":"androgen receptor pathway inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9900000095367432},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9257524609565735},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.856855034828186},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.730223536491394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.587644100189209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5355104804039001},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5351003408432007},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3910055160522461},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30615419149398804}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.26226/morressier.5f4d10acb0f0f3411b83095c","doi":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c","is_oa":false,"landing_page_url":"https://doi.org/10.26226/morressier.5f4d10acb0f0f3411b83095c","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3154460154","https://openalex.org/W2221430323","https://openalex.org/W2792598861","https://openalex.org/W2101496134","https://openalex.org/W4245525106","https://openalex.org/W2941414418","https://openalex.org/W4391303644","https://openalex.org/W4387692029","https://openalex.org/W2588035227","https://openalex.org/W4324136602"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2022-05-11T00:00:00"}